Department of Dermatology, Xijing Hospital, Fourth Military Medical University, 127 Changlexi Road, Xi'an, 710032, Shaanxi, People's Republic of China.
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
J Clin Immunol. 2019 Oct;39(7):713-725. doi: 10.1007/s10875-019-00679-4. Epub 2019 Aug 14.
In the past decade, an increasing number of otherwise healthy individuals suffered from invasive fungal infections due to inherited CARD9 mutations. Herein, we present a patient with a homozygous CARD9 mutation who was suffering from localized subcutaneous phaeohyphomycosis caused by the phytopathogenic fungus Pallidocercospora crystallina which has not been reported to cause infections in humans.
The medical history of our patient was collected. P. crystallina was isolated from the biopsied tissue. To characterize this novel pathogen, the morphology was analyzed, whole-genome sequencing was performed, and the in vivo immune response was explored in mice. Whole-exome sequencing was carried out with samples from the patient's family. Finally, the expression and function of mutated CARD9 were investigated.
A dark red plaque was on the patient's left cheek for 16 years and was diagnosed as phaeohyphomycosis due to a P. crystallina infection. Whole-genome sequencing suggested that that this strain had a lower pathogenicity. The in vivo immune response in immunocompetent or immunocompromised mice indicated that P. crystallina could be eradicated within a few weeks. Whole-exome sequencing revealed ahomozygous missense mutation in CARD9 (c.1118G>C p.R373P). The mRNA and protein expression levels were similar among cells carrying homozygous (C/C), heterozygous (G/C), and wild-type (G/G) CARD9 alleles. Compared to PBMCs or neutrophils with heterozygous or wild-type CARD9 alleles, however, PBMCs or neutrophils with homozygous CARD9 alleles showed impaired anti-P. crystallina effects.
Localized subcutaneous phaeohyphomycosis caused by P. crystallina was reported in a patient with a homozygous CARD9 mutation. Physicians should be aware of the possibility of a CARD9 mutation in seemingly healthy patients with unexplainable phaeohyphomycosis.
在过去十年中,由于 CARD9 基因突变,越来越多原本健康的个体患上侵袭性真菌感染。本文报道了一例 CARD9 纯合突变患者,该患者患有由植物病原真菌拟盘多毛孢(Pallidocercospora crystallina)引起的局限性皮下暗色丝孢霉病,而该真菌尚未被报道可引起人类感染。
收集患者的病史。从活检组织中分离出 P. crystallina。为了对这种新型病原体进行特征描述,我们对其形态进行了分析、进行了全基因组测序,并在小鼠体内探索了其免疫反应。对患者家系样本进行了外显子组测序。最后,研究了突变 CARD9 的表达和功能。
患者左侧脸颊有一暗红色斑块 16 年,被诊断为拟盘多毛孢感染引起的暗色丝孢霉病。全基因组测序提示该菌株的致病性较低。免疫功能正常或免疫功能低下的小鼠体内的免疫反应表明,P. crystallina 可在数周内被清除。外显子组测序显示 CARD9 存在纯合错义突变(c.1118G>C p.R373P)。携带纯合子(C/C)、杂合子(G/C)和野生型(G/G)CARD9 等位基因的细胞中,mRNA 和蛋白表达水平相似。然而,与携带杂合或野生型 CARD9 等位基因的 PBMC 或中性粒细胞相比,携带纯合 CARD9 等位基因的 PBMC 或中性粒细胞对 P. crystallina 的抗真菌作用受损。
报道了一例 CARD9 纯合突变患者发生由 P. crystallina 引起的局限性皮下暗色丝孢霉病。对于原因不明的暗色丝孢霉病,疑似健康的患者也可能存在 CARD9 基因突变,临床医生应注意这一可能性。